Multiple Defendants Charged In Allegheny County-Beaver County Prescription Drug Ring
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Multiple Defendants Charged In Allegheny County-Beaver County Prescription Drug Ring

Multiple Defendants Charged In Allegheny County-Beaver County Prescription Drug Ring

July 23, 2013
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Media Requests
Phone Number: (215) 861-3474

JULY 23 - ( - PITTSBURGH) - Twelve western Pennsylvania residents have been indicted by a federal grand juryalleging their participation in a prescription drug ring operating in Allegheny and Beaver Counties, United States Attorney David J. Hickton announced today. The indictments were returned on July16, 2013, and unsealed this week.

“These indictments charge participants at all levels of a western Pennsylvania oxycodone and Opana distribution ring - from the leader, to the prescription thief, to the pharmacy burglars, to the runners who presented the fake prescriptions to be filled,” said U.S. Attorney Hickton. “Dismantling these operations continues to be a priority of this office as we endeavor to address the prescription drug abuse epidemic. As this case illustrates, abuse of prescription pills can result in grave harm and death.”

“Prescription drug abuse encompasses far more than the act of selling drugs; it often involves property crimes and crimes of violence. It is a serious threat to our communities and children. In 2011 for example, there were 2.3 million persons age 12 and older who used prescription drugs for the first time for non-medical reasons,” said Drug Enforcement (DEA) Special Agent in Charge David G. Dongilli. “DEA is committed to confronting this threat to public health and will continue to target those who would profit from the illegal sales of prescription drugs without regard to the damage it causes to people and communities. DEA wishes to thank the U.S. Attorney’s Office for their support in this prosecution.”

A 12-count indictment charging violations of federal narcotics, firearms and burglary laws named :
• David Best, 27, of 501 Graydon Drive, Coraopolis, Pa., 15108;
• Matthew Moody, 24, of 102 Rock Rose Drive, Baden, Pa., 15005;
• Jade Gagianas, 28, of 142 Pinehurst Drive, Freedom, Pa., 15042;
• Katie Adams, 27, of 532 Maplewood Avenue, Ambridge, Pa., 15003;
• Andrew Brown, 23, of 698 Vanceville Road, Eighty Four, Pa., 15330;
• Ryan Raithel, 33, of 10450 Meinert Road, Wexford, Pa., 15090; and,
• Carlos Martinez, 26, of 532 Maplewood Avenue, Ambridge, Pa., 15003.

Count 1 charges Best, Moody, Gagianas, Adams, Brown, and Raithel with conspiring together and with others, from around December 2011 until May 2013, to distribute and possess with intent to distribute the Schedule II controlled substances oxycodone and oxymorphone, in the form known as Opana.

Counts 2 through 4 charge Best with distributing oxycodone and oxymorphone, in the form known as Opana, on May 8, 2012, April 18, 2013, and April 30, 2013. Count 4 alleges that when Best distributed both oxycodone and Opana on May 8, 2012, a person known to the grand jury died as a result of his use of the drugs.

Count 5 charges that Best, on or about June 20, 2012, used, carried, and brandished a firearm during and in relation to a drug trafficking (the conspiracy).

Counts 6 through 11 reflect charges that on three occasions, Dec. 1, 2011, Sept. 26-27, 2012, and Feb. 15, 2013, Best burglarized the MedFast pharmacy in Baden, Pa., and from that pharmacy stole a number of Schedule II controlled substances, including: fentanyl, oxymorphone, including in the form known as Opana, Ritalin, oxycodone, including in the form known as Oxycontin, methylphenidate, Vyvanse, morphine sulfate, Roxicet, Focalin, methylphenidate, hydromorphone, methadone, and meperidine. Adams and Martinez are also charged with the Sept. 26-27, 2012, burglary of that pharmacy.

Finally, Count 12 charges Raithel with distributing a quantity of a mixture and substance containing a detectable amount of heroin, a Schedule I controlled substance, on or about Aug. 10, 2012.

On the drug conspiracy charge, the possession with the intent to distribute and distribution charges, and pharmacy burglary charges, the law provides for a maximum total sentence as to each count of 20 years in prison, a fine of up to $1,000,($250,000 for the pharmacy burglaries), or both. When death results from the use of illegally distributed Schedule I or II drugs, the penalty increases to a mandatory minimum of 20 years and a maximum of life imprisonment. Finally, for the firearms charge, there is a mandatory minimum of seven years, a maximum of life imprisonment, and a fine of up to $250,000. Any penalty imposed on the firearms charge must run consecutively to any other penalty. Under the Federal Sentencing Guidelines, the actual sentence imposed would be based upon the seriousness of the offenses and the prior criminal history, if any, of the defendants.

In a separate but related indictment, two residents of Western Pennsylvania have been indicted on a charge of witness intimidation. The one-count indictment named: • Natalie Moskorisin, 23, of 1046 Highland Avenue, Ambridge, Pa., 15003; and • Wesley Weaver, 23, of 501 Graydon Drive, Coraopolis, Pa 15108.

According to the indictment, on or about June 6, 2013, in the Western District of Pennsylvania, Moskorisin and Weaver knowingly intimidated and attempted to intimidate witnesses in a federal proceeding, that being the federal investigation and prosecution of David Best.

The law provides for a maximum total sentence of 10 years in prison, a fine of $250,000, or both. Under the Federal Sentencing Guidelines, the actual sentence imposed would be based upon the seriousness of the offense and the prior criminal history, if any, of the defendants.

Three additional Pittsburgh-area residents were indicted separately on charges of violating federal narcotic laws.

A one-count indictment charges that on Sept. 19, 2012, Janna Gahagan, 29, of 8515 Forest Avenue, Pittsburgh, Pa., conspired with others to obtain oxycodone by fraud, in that she passed a fraudulent oxycodone prescription at a pharmacy, thereby obtaining oxycodone pursuant to that fraudulent prescription.

Another one-count indictment charges that from March 23, 2012, and continuing until July 17, 2012, Breanne McKee, 29, of 216 Oak Leaf Drive, Saxonburg, Pa., 16056, conspired with others to obtain oxycodone and oxymorphone, in the form known as Opana, by fraud, in that she passed fraudulent prescriptions at area pharmacies, thereby obtaining oxycodone and oxymorphone pursuant to those fraudulent prescriptions.

Finally, a one-count indictment charges that on or about April 26, 2013, Christopher Nugent, 34, of 8947 Harmony Drive, Pittsburgh, Pa., conspired with others to obtain oxycodone by fraud, in that he passed a fraudulent oxycodone prescription at a pharmacy, thereby obtaining oxycodone pursuant to that fraudulent prescription.

For Gahagan, McKee and Nugent, the law provides for a maximum total sentence of not more than four years in prison, a fine of $250,000, or both. Under the Federal Sentencing Guidelines, the actual sentence imposed would be based upon the seriousness of the offense and the prior criminal history, if any, of the defendant.

Assistant United States Attorney Eric S. Rosen is prosecuting these cases on behalf of the government.

The Drug Enforcement Administration and the Economy Borough and Cranberry Township Police Departments conducted the investigation leading to the indictment in these cases.

An indictment is an accusation. A defendant is presumed innocent unless and until proven guilty.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Thomas Hodnett Special Agent in Charge - Philadelphia
@DEAPhiladelphia
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español